SUBSCRIBE
SUBSCRIBE

Bolden Therapeutics

IN THE PRESS
Press Releases
Bolden Therapeutics to Present at the 4th Annual Oligonucleotides for CNS Summit
July 11, 2024
 · 
2 min read
Biotech Beach
BOLDEN THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS
January 17, 2024
 · 
2 min read
Genetown
BOLDEN THERAPEUTICS TO PRESENT AT THE 3RD ANNUAL OLIGONUCLEOTIDES FOR CNS SUMMIT
June 7, 2023
 · 
1 min read
Genetown
BOLDEN THERAPEUTICS RECEIVES $406,466 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS
September 16, 2022
 · 
2 min read
Genetown
Bolden Therapeutics Receives $497,500 SBIR Grant From the National Institute on Aging to Support Development of Antisense Oligonucleotides to Promote Neurogenesis
June 29, 2022
 · 
1 min read
JOBS